25% of Patients Achieve Endoscopic Remission in Phase 2a EMERALD-1 Trial for MORF-057

Press/Media

Period	25 Sep 2023

Media coverage

Title	25% of Patients Achieve Endoscopic Remission in Phase 2a EMERALD-1 Trial for MORF-057
Media name/outlet	Consultant Live
Country/Territory	United States
Date	25/09/23
URL	ct.moreover.com/?a=51896365610&p=1gw&v=1&x=uTzHYYmUjfHQewrlbMvNqg
Persons	Bruce E. Sands

Title	25% of Patients Achieve Endoscopic Remission in Phase 2a EMERALD-1 Trial for MORF-057
Media name/outlet	HCPLive
Country/Territory	United States
Date	25/09/23
URL	ct.moreover.com/?a=51896515141&p=1gw&v=1&x=f-MgPZcj95Usgha94FoFLQ
Persons	Bruce E. Sands